FDA’s Quality System Regulation (QSR)

With the growing reliance on interconnected technology, cybersecurity risks in medical devices have become a top priority for regulators and manufacturers alike. The FDA recognizes that robust cybersecurity controls are essential to ensure medical device safety, effectiveness, and patient protection. The cornerstone of these efforts is the Quality System Regulation (QSR), a set of guidelines manufacturers must follow to comply with FDA requirements and deliver secure medical devices to the market.

Key Takeaways

• QSR mandates cybersecurity integration across device lifecycle.
• Implement a Secure Product Development Framework (SPDF).
• Conduct continuous cybersecurity risk management.
• Provide clear cybersecurity transparency via SBOMs.
• Submit strong cybersecurity documentation to the FDA.
• Proactive measures protect device safety and patient health.

Table of Contents

• Key Takeaways
• The Importance of Cybersecurity in Medical Devices
• Key Cybersecurity Elements of the FDA’s QSR
• Practical Steps to Ensure Compliance
• How Blue Goat Cyber Can Help
• Take the Next Step in Medical Device Cybersecurity

Why this matters

Compromised medical device cybersecurity can directly lead to patient harm, data breaches, and operational disruptions within healthcare systems. The FDA, in its 'Cybersecurity in Medical Devices' Final Guidance dated February 3, 2026, emphasizes that cybersecurity is a critical component of device safety and effectiveness, falling squarely under the Quality System Regulation (QSR). Non-compliance can result in regulatory actions, market delays, and significant reputational damage for manufacturers. Adhering to QSR cybersecurity requirements necessitates integrating security practices across the entire product lifecycle, from design to post-market surveillance. This involves adopting frameworks like a Secure Product Development Framework (SPDF) and aligning with standards such as IEC 81001-5-1 and ISO 14971, which address health software lifecycle processes and risk management for medical devices. For diagnostic devices, AAMI TIR97 provides guidance on security requirements. Proactively addressing these requirements not only fulfills regulatory obligations but also builds trust with healthcare providers and patients, ensuring the sustained safety and reliability of medical technology.

The Importance of Cybersecurity in Medical Devices

Medical devices today increasingly feature wireless connectivity, software integration, and remote update capabilities. While these advancements enhance healthcare delivery, they simultaneously introduce significant cybersecurity risks. The rising threat landscape-including attacks like WannaCry ransomware and vulnerabilities such as URGENT/11-illustrates the potential patient safety implications when medical devices are compromised.

The FDA emphasizes that cybersecurity is inherently linked to device safety and quality assurance. An unaddressed vulnerability can lead to critical consequences, such as disruption in patient care, inaccurate diagnostics, or even direct harm to patients. Thus, proactive cybersecurity risk management is critical.

Key Cybersecurity Elements of the FDA’s QSR

To navigate these challenges effectively, the FDA outlines several essential cybersecurity components manufacturers must incorporate into their QSR compliance efforts:

1. Secure Product Development Framework (SPDF)

The FDA strongly encourages medical device manufacturers to implement a Secure Product Development Framework (SPDF). An SPDF is an integrated, systematic process that incorporates cybersecurity into every stage of product development-from initial design to ongoing post-market support. By following SPDF guidelines, manufacturers can proactively mitigate cybersecurity risks throughout the device’s lifecycle.

2. Cybersecurity Risk Management and Threat Modeling

Central to FDA guidelines is the need for thorough cybersecurity risk assessments and threat modeling. These activities involve:

• Identifying potential threats that could exploit vulnerabilities.
• Analyzing and evaluating risks based on the likelihood and potential impact of these threats.
• Applying mitigations to reduce risks to acceptable levels.

Risk management is not a one-time effort but an ongoing process throughout the device lifecycle. Manufacturers must continuously monitor and address emerging threats to maintain a secure and compliant product.

3. Cybersecurity Transparency

The FDA emphasizes transparency as crucial for managing cybersecurity risks effectively. Manufacturers are expected to provide clear and thorough documentation about the device’s cybersecurity features, potential risks, and recommended maintenance practices. This includes providing:

• Detailed cybersecurity labeling outlining risks, protection measures, and user responsibilities.
• A comprehensive Software Bill of Materials (SBOM) detailing all software components within a device to facilitate rapid identification and mitigation of vulnerabilities.

4. Submission Documentation

To support premarket submissions, the FDA requires manufacturers to provide robust cybersecurity documentation, including:

See also: SPDF and IEC 62304 Mapping: FDA Cyber Guide, FDA Penetration Testing Requirements for Medical Devices, and Letter to File vs New 510(k) for Cybersecurity Changes.

• Cybersecurity management plans clearly outlining how cybersecurity risks are addressed.
• Detailed security architecture diagrams showing how security controls are integrated within the device.
• Evidence from comprehensive cybersecurity testing, verifying that the implemented controls effectively mitigate identified risks.

Practical Steps to Ensure Compliance

Manufacturers can achieve and maintain FDA cybersecurity compliance by taking the following practical steps:

• Integrate cybersecurity early in the device design phase, applying SPDF best practices from the outset.
• Conduct and document regular cybersecurity risk assessments, incorporating findings into ongoing device improvements.
• Implement and validate robust security controls, including authentication, encryption, and secure software updates.
• Ensure ongoing cybersecurity training for all relevant personnel, emphasizing a culture of cybersecurity awareness.

How Blue Goat Cyber Can Help

Navigating FDA cybersecurity requirements can be complex, but Blue Goat Cyber simplifies the process by leveraging deep industry experience and proven cybersecurity methodologies. Our dedicated cybersecurity experts work closely with your team to:

• Perform complete cybersecurity risk assessments and threat modeling.
• Develop customized Secure Product Development Frameworks (SPDF) tailored to your specific device and regulatory needs.
• Prepare thorough FDA premarket cybersecurity documentation, including cybersecurity management plans, SBOMs, and security architecture diagrams.
• Provide ongoing post-market support, ensuring your devices remain secure against evolving threats.

By partnering with Blue Goat Cyber, you can streamline compliance efforts, accelerate FDA clearance timelines, and confidently deliver secure, innovative medical devices to market.

Take the Next Step in Medical Device Cybersecurity

Ensure your medical device is secure, compliant, and prepared to withstand cybersecurity threats with the expert support of Blue Goat Cyber. Our team is ready to guide you through every stage of cybersecurity management, helping you protect your devices, your brand, and-most importantly-your patients.

Contact Blue Goat Cyber today to discuss your medical device cybersecurity needs and discover how we can ensure your device is FDA-ready and protected against evolving threats.

FAQ

What is the QSR's role in medical device cybersecurity?

The QSR requires medical device manufacturers to include cybersecurity as part of their quality management system. This ensures devices are designed, manufactured, and maintained to be secure against cyber threats, directly impacting patient safety and device effectiveness.

How does an SPDF relate to FDA cybersecurity compliance?

An SPDF is a structured approach recommended by the FDA to embed cybersecurity activities into every phase of device development. This includes design, testing, and post-market maintenance, helping manufacturers address risks proactively.

Why is cybersecurity risk management important for medical devices?

Cybersecurity risk management identifies, assesses, and mitigates potential threats to medical devices. This ongoing process helps prevent compromises that could disrupt patient care, compromise data, or cause direct harm, as outlined in the February 3, 2026 FDA premarket cybersecurity guidance.

What is an SBOM and why does the FDA require it?

An SBOM (Software Bill of Materials) lists all software components in a medical device. The FDA requires it to enhance transparency, enabling rapid identification and mitigation of vulnerabilities, which is critical for post-market security management.

Does the FDA require cybersecurity testing for device approval?

Yes, for premarket submissions, the FDA expects evidence from complete cybersecurity testing. This verifies that implemented security controls effectively mitigate identified risks and ensure the device's overall safety and security.

When should cybersecurity be considered in medical device development?

Cybersecurity should be integrated early in the device design phase and continuously throughout the entire product lifecycle. This approach, emphasized by the FDA, ensures that security is 'built-in' rather than 'bolted-on'.

Related: Medical Device Cybersecurity: A Complete Lifecycle Guide

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.